Brief: DSS’s Subsidiary, Impact Biomedical, Announces Strategic Merger
24/06/2025 13:31
June 24 (Reuters) - Dss Inc DSS.A: DSS, INC.’S SUBSIDIARY, IMPACT BIOMEDICAL INC., ANNOUNCES STRATEGIC MERGER DSS INC - REVERSE MERGER TO FORM NEW ENTITY TRADED AS DR ASHLEYS LIMITED DSS INC - TO HOLD 4.80% OF COMBINED COMPANY'S SHARES Source text: ID:nGNX5ZGTbq Further company coverage: DSS.A ((Reuters.Briefs@thomsonreuters.com;))
Recent news on DSS
See all newsBrief: Dss Withdraws S-1 Registration Statement With SEC
Brief: Dss Reports Going Concern Audit Opinion In 2025 10-K Filing
Brief: Dss Inc Actively Evaluating Acquisition Opportunities Within Folding Carton Space
Brief: Dss, Inc. Announces Pricing Of $1.0 Million Underwritten Public Offering
Brief: DSS’s Subsidiary, Impact Biomedical, Announces Strategic Merger